Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Roepstorff

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Exercise and Sport Sciences Reviews|October 22, 2005
Intramuscular triacylglycerol in energy metabolism during exercise in humansCarsten Roepstorff, Bodil Vistisen, Bente Kiens
American Journal of Physiology. Endocrinology and Metabolism|June 10, 2004
Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exerciseCarsten Roepstorff, Bodil Vistisen, Kirstine Roepstorff, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 8, 2002
Myocellular triacylglycerol breakdown in females but not in males during exerciseCharlotte H Steffensen, Carsten Roepstorff, Marianne Madsen, et al.
Clinical Drug Investigation|November 27, 2013
Insulin degludec: pharmacokinetic properties in subjects with hepatic impairmentViera Kupčová, Gerhard Arold, Carsten Roepstorff, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 4, 2014
Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes MellitusTim Heise, Leszek Nosek, Carsten Roepstorff, et al.
Clinical Pharmacokinetics|October 29, 2013
Insulin degludec: pharmacokinetics in patients with renal impairmentIstván Kiss, Gerhard Arold, Carsten Roepstorff, et al.
Journal of Lipid Research|January 20, 2004
Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibersBodil Vistisen, Kirstine Roepstorff, Carsten Roepstorff, et al.
Clinical Therapeutics|February 11, 2014
Pharmacokinetic and pharmacodynamic responses of insulin degludec in African American, white, and Hispanic/Latino patients with type 2 diabetes mellitusMarcus Hompesch, Linda Morrow, Elaine Watkins, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 29, 2007
Effect of sex differences on human MEF2 regulation during endurance exerciseKristian Vissing, Sean L McGee, Carsten Roepstorff, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 4, 2009
Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signalingLouise Høeg, Carsten Roepstorff, Maja Thiele, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Exercise and Sport Sciences Reviews|October 22, 2005
Intramuscular triacylglycerol in energy metabolism during exercise in humansCarsten Roepstorff, Bodil Vistisen, Bente Kiens
American Journal of Physiology. Endocrinology and Metabolism|June 10, 2004
Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exerciseCarsten Roepstorff, Bodil Vistisen, Kirstine Roepstorff, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 8, 2002
Myocellular triacylglycerol breakdown in females but not in males during exerciseCharlotte H Steffensen, Carsten Roepstorff, Marianne Madsen, et al.
Clinical Drug Investigation|November 27, 2013
Insulin degludec: pharmacokinetic properties in subjects with hepatic impairmentViera Kupčová, Gerhard Arold, Carsten Roepstorff, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 4, 2014
Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes MellitusTim Heise, Leszek Nosek, Carsten Roepstorff, et al.
Clinical Pharmacokinetics|October 29, 2013
Insulin degludec: pharmacokinetics in patients with renal impairmentIstván Kiss, Gerhard Arold, Carsten Roepstorff, et al.
Journal of Lipid Research|January 20, 2004
Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibersBodil Vistisen, Kirstine Roepstorff, Carsten Roepstorff, et al.
Clinical Therapeutics|February 11, 2014
Pharmacokinetic and pharmacodynamic responses of insulin degludec in African American, white, and Hispanic/Latino patients with type 2 diabetes mellitusMarcus Hompesch, Linda Morrow, Elaine Watkins, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 29, 2007
Effect of sex differences on human MEF2 regulation during endurance exerciseKristian Vissing, Sean L McGee, Carsten Roepstorff, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 4, 2009
Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signalingLouise Høeg, Carsten Roepstorff, Maja Thiele, et al.
Pageof 3